Search

Clinical Trial

A Phase 1, Open-Label, Dose-Escalation and -Expansion Study of the Bruton Tyrosine Kinase-Targeted Protein-Degrader BGB-16673 in Patients With B-Cell Malignancies

… BGB-16673 in Patients With B-Cell Malignancies I Cortese, Matthew J Study consists of two main parts to …

Clinical Trial

A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in Participants With Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011)

… Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011) III Cortese, Matthew J The goal of this study is to evaluate nemtabrutinib …